SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-22-073816
Filing Date
2022-11-18
Accepted
2022-11-18 16:05:18
Documents
1
Group Members
ALVOGEN LUX HOLDINGS S.A R.L.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea168895-13da2celtic_alvo.htm SC 13D/A 65886
  Complete submission text file 0001213900-22-073816.txt   67476
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Subject) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93700 | Film No.: 221401951
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20, AVENUE MONTEREY LUXEMBOURG N4 L-2163
Business Address 20, AVENUE MONTEREY LUXEMBOURG N4 L-2163 01135220880825
Celtic Holdings SCA (Filed by) CIK: 0001935390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A